AstraZeneca to buy Ontario cancer treatment developer Fusion Pharmaceuticals
Fusion, based in Hamilton, is focused on developing radioconjugates which are used to deliver radiation directly to cancer cells.
Fusion, based in Hamilton, is focused on developing radioconjugates which are used to deliver radiation directly to cancer cells.
